Concomitant use of insulin glargine and NPH in type I diabetes

Indian Pediatr. 2005 Aug;42(8):796-800.

Abstract

In a prospective study on 11 patients with Type 1 diabetes we evaluated the glycaemic control and hypoglycaemic episodes on a combination therapy of pre-mixed and glargine insulin. Glycosylated hemoglobin (HbA1C), fasting (FPG) and Post Prandial blood glucose (PPG) levels were recorded at baseline and three monthly intervals for a period of 6 months. The mean HbA1C reduced from 9.5 to 7.3 %, incidence of hypoglycemias from 1.6 to 0.8, mean FPG from 146.5 to 90.4 and mean PPG from 258.4 to 184 over a six-month observation period. This regimen also helps to avoid injection of insulin before lunch so that child's school schedule is minimally disturbed and yet the incidence of hypoglycemia is not increased.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Blood Glucose / metabolism
  • Child
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Glycated Hemoglobin / metabolism
  • Humans
  • Hypoglycemia / prevention & control
  • Insulin / administration & dosage
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Glargine
  • Insulin, Isophane / administration & dosage*
  • Insulin, Isophane / therapeutic use
  • Insulin, Long-Acting
  • Male
  • Prospective Studies

Substances

  • Blood Glucose
  • Drug Combinations
  • Glycated Hemoglobin A
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine
  • Insulin, Isophane